Thiolactones

Details Thiolactones Thiolactones

2011-06-28

2011-06-28

Nolan, Jason M (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C549S023000

Reexamination Certificate

active

07968593

ABSTRACT:
This invention provides new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, inhibiting angiogenesis, effecting a TGF-β activity or a neuronal activity, and treating a glutamate abnormality, a compulsive disorder, neuropathy, pain, a prostate disease, cancer, Huntington's disease, diabetes, a retinal disorder or glaucoma.

REFERENCES:
patent: 4239636 (1980-12-01), Brois et al.
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5795877 (1998-08-01), Jackson et al.
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5824662 (1998-10-01), Slusher et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5977090 (1999-11-01), Slusher et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 5985855 (1999-11-01), Slusher et al.
patent: 6004946 (1999-12-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6028216 (2000-02-01), Morales et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6071965 (2000-06-01), Jackson et al.
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6228888 (2001-05-01), Slusher
patent: 6265609 (2001-07-01), Jackson et al.
patent: 6271245 (2001-08-01), Jackson et al.
patent: 6288046 (2001-09-01), Jackson et al.
patent: 6313159 (2001-11-01), Jackson et al.
patent: 6348464 (2002-02-01), Jackson et al.
patent: 6372726 (2002-04-01), Slusher et al.
patent: 6376478 (2002-04-01), Slusher
patent: 6384022 (2002-05-01), Jackson et al.
patent: 6395718 (2002-05-01), Slusher et al.
patent: 6413948 (2002-07-01), Slusher et al.
patent: 6444657 (2002-09-01), Slusher et al.
patent: 6452044 (2002-09-01), Jackson et al.
patent: 6458775 (2002-10-01), Jackson et al.
patent: 6479471 (2002-11-01), Jackson et al.
patent: 6586623 (2003-07-01), Tsukamoto et al.
patent: 6740777 (2004-05-01), Tsukamoto et al.
patent: 6812364 (2004-11-01), Tsukamoto et al.
patent: 7125907 (2006-10-01), Slusher et al.
patent: 7553866 (2009-06-01), Slusher et al.
patent: 2003/0017965 (2003-01-01), Slusher et al.
patent: 2003/0036534 (2003-02-01), Slusher et al.
patent: 2003/0064912 (2003-04-01), Slusher et al.
patent: 2003/0083374 (2003-05-01), Jackson et al.
patent: 2003/0083505 (2003-05-01), Jackson et al.
patent: 2003/0087897 (2003-05-01), Tsukamoto et al.
patent: 2003/0216468 (2003-11-01), Tsukamoto et al.
patent: 2004/0186081 (2004-09-01), Slusher et al.
patent: 2004/0198824 (2004-10-01), Tsukamoto et al.
patent: 2005/0004203 (2005-01-01), Slusher et al.
patent: 2007/0037798 (2007-02-01), Slusher et al.
patent: 2008/0004334 (2008-01-01), Slusher et al.
patent: 2434117 (2002-07-01), None
patent: 1 988 088 (2008-11-01), None
patent: 2 819 253 (2002-07-01), None
patent: WO 94/05687 (1994-03-01), None
patent: WO 01/01974 (2001-01-01), None
patent: WO 01/91738 (2001-12-01), None
patent: WO 02/057222 (2002-07-01), None
Collins,Expert Opin. Emerging Drugs10(1):95-108 (2005), in prior U.S. Appl. No. 10/791,278.
Direction to Request Examination mailed Jul. 31, 2007, herewith.
Derwent WPI Abstract (English language Abstract) for FR 2 819 253, in prior U.S. Appl. No. 10/791,278, Jul. 12, 2002.
Examiner's First Report, Australian Patent Application. No. 2004217969, herewith, (Jun. 11, 2009).
European Search Report, European Appln. No. 08 01 3761 (European Published Application No. EP 1 988 088 A1), (2008), in prior U.S. Appl. No. 11/830,737.
Hannessian et al., “N-Aryl Sulfonyl Homocysteine Hydroxamate Inhibitors of Matrix Metalloproteinases”,J. Med. Chem. 44:3066-3073 (2001), in prior U.S. Appl. No. 10/791,278.
International Search Report (PCT/US2004/006178) (2004), in prior U.S. Appl. No. 10/791,278.
Jackson et al., “Design of NAALADase Inhibitors: A Novel Neuroprotective Strategy”,Current Medicinal Chemistry8:949-957 (2001), in prior U.S. Appl. No. 10/791,278.
Morissette et al., “High-Throughout Crystallization: Polymorphs, Salts, Co-Crystals and Solvates of Pharmaceutical Solids”,Advanced Drug Delivery Reviews, 56:275-300 (2004), in prior U.S. Appl. No. 11/537,979.
Non-Final Office Action, U.S. Appl. No. 11/537,979 (Oct. 2, 2006), herewith.
Non-Final Office Action, U.S. Appl. No, 11/830,737 (Jul. 30, 2007), herewith.
Takahata et al., “Regloselective Thio-Claisen Rearrangement”,Heterocycles24(12):3347-3350 (1986) , in prior U.S. Appl. No. 10/791,278.
Tokmakov, “α-Dimethylaminomethylene-γ-Thiobutyrolactone and Synthesis of Heterocyclic Derivatives”,Chemistry of Heterocycle Compounds32(2) (1996), in prior U.S. Appl. No. 10/791,278.
Written Opinion of the International Searching Authority—PCT Rule 43bis.1, mailed Jul. 30, 2004, herewith.
Ghadge et al., “Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models,”PNAS, 100(16):9554-9559 (Aug. 5, 2003), hereewith.
Jackson et al., “Design and Pharmacological Activity of Phosphinic Acid Based NAALADase Inhibitors,”J. Med. Chem, 44:4170-4175 (2001), hereewith.
Slusher et al., “Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury,”Nature Medicine, 3(12):1396-1402 (Dec. 1999), herewith.

Affiliated with

Also associated with

Rating

Thiolactones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiolactones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiolactones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2670189